Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells
Open accessAbstract
Chemokines and chemokine receptors play important roles in migration and tissue localization of various lymphocyte subsets. Here, we report the highly frequent expression of CCR4 in adult T-cell leukemia (ATL) and human T-cell leukemia virus type 1 (HTLV-1)–immortalized T cells. Flow cytometric analysis revealed that ATL and HTLV-1–immortalized T-cell lines consistently expressed CCR4. Inducible expression of HTLV-1 transcriptional activator tax in a human T-cell line Jurkat did not, however, up-regulate CCR4 mRNA. In vitro immortalization of peripheral blood T cells led to preferential outgrowth of CD4+ T cells expressing CCR4. We further demonstrated highly frequent expression of CCR4 in fresh ATL cells by (1) reverse transcriptase–polymerase chain reaction (RT-PCR) analysis of CCR4 expression in peripheral blood mononuclear cells (PBMCs) from patients with ATL and healthy controls; (2) flow cytometric analysis of CCR4-expressing cells in PBMCs from patients with ATL and healthy controls; (3) CCR4 staining of routine blood smears from patients with ATL; and (4) an efficient migration of fresh ATL cells to the CCR4 ligands, TARC/CCL17 and MDC/CCL22, in chemotaxis assays. Furthermore, we detected strong signals for CCR4, TARC, and MDC in ATL skin lesions by RT-PCR. Collectively, most ATL cases have apparently derived from CD4+ T cells expressing CCR4. It is now known that circulating CCR4+ T cells are mostly polarized to Th2 and also contain essentially all skin-seeking memory T cells. Thus, HTLV-1–infected CCR4+ T cells may have growth advantages by deviating host immune responses to Th2. CCR4 expression may also account for frequent infiltration of ATL into tissues such as skin and lymph nodes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mogamulizumab targets CCR4, a chemokine receptor highly expressed by HTLV-1-infected T cells, with phase I and II clinical trials resulting in an overall response rate (ORR) of 50%.
“Mogamulizumab targets CCR4, a chemokine receptor highly expressed by HTLV-1-infected T cells [198,199,200], with phase I and II clinical trials resulting in an overall response rate (ORR) of 50% [201,202,203].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [198]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340 · see citing works
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359 · see citing works
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.184.3.963 · Cited by 1,333 · see citing works
Cole, K. E., Strick, C. A., Paradis, T. J., Ogborne, K. T., Loetscher, M., Gladue, R. P., Lin, W., Boyd, J. G., Moser, B., Wood, D. E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2009 · Cited by 870 · see citing works
Legler, D. F., Loetscher, M., Roos, R. S., Clark‐Lewis, I., Baggiolini, M., & Moser, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.655 · Cited by 838 · see citing works
The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
Campbell, J. J., Haraldsen, G., Pan, J., Rottman, J. B., Qin, S., Ponath, P. D., Andrew, D. P., Warnke, R. A., Ruffing, N., Kassam, N., et al. (1999) · Nature · doi:10.1038/23495 · Cited by 833 · see citing works
A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1
Gunn, M. D., Ngo, V. N., Ansel, K. M., Ekland, E. H., Cyster, J. G., & Williams, L. T. (1998) · Nature · doi:10.1038/35876 · Cited by 825 · see citing works
Imai, T., Nagira, M., Takagi, S., Kakizaki, M., Nishimura, M., Wang, J., Gray, P. W., Matsushima, K., & Yoshie, O. (1999) · International Immunology · doi:10.1093/intimm/11.1.81 · Cited by 720 · see citing works
Self-citationImai, T., Baba, M., Nishimura, M., Kakizaki, M., Takagi, S., & Yoshie, O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.15036 · Cited by 555 · see citing works
Self-citationIn vivo cellular tropism of human T-cell leukemia virus type 1
Richardson, J. H., Edwards, A. J., Cruickshank, J. K., Rudge, P., & Dalgleish, A. G. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5682-5687.1990 · Cited by 429 · see citing works
Yoshie, O., Imai, T., & Nomiyama, H. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)78002-9 · Cited by 428 · see citing works
Self-citationOverproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis–like lesions
Vestergaard, C., Yoneyama, H., Murai, M., Nakamura, K., Tamaki, K., Terashima, Y., Imai, T., Yoshie, O., Irimura, T., Mizutani, H., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7613 · Cited by 406 · see citing works
Self-citationYoshida, R., Imai, T., Hieshima, K., Kusuda, J., Baba, M., Kitaura, M., Nishimura, M., Kakizaki, M., Nomiyama, H., & Yoshie, O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13803 · Cited by 395 · see citing works
Self-citationHUMAN T CELL LEUKEMIA VIRUS TYPE I (HTLV-I) AND HUMAN DISEASES
Uchiyama, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.15 · Cited by 390 · see citing works
Macrophage-derived Chemokine Is a Functional Ligand for the CC Chemokine Receptor 4
Imai, T., Chantry, D., Raport, C. J., Wood, C. L., Nishimura, M., Godiska, R., Yoshie, O., & Gray, P. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1764 · Cited by 378 · see citing works
Self-citationVestergaard, C., Bang, K., Gesser, B., Yoneyama, H., Matsushima, K., & Larsen, C. G. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00115.x · Cited by 348 · see citing works
Self-citationSecondary Lymphoid-tissue Chemokine Is a Functional Ligand for the CC Chemokine Receptor CCR7
Yoshida, R., Nagira, M., Kitaura, M., Imagawa, N., Imai, T., & Yoshie, O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.7118 · Cited by 320 · see citing works
Self-citationSekiya, T., Miyamasu, M., Imanishi, M., Yamada, H., Nakajima, T., Yamaguchi, M., Fujisawa, T., Pawankar, R., Sano, Y., Ohta, K., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2205 · Cited by 280 · see citing works
Self-citationNagata, K., Ohtani, K., Nakamura, M., & Sugamura, K. (1989) · Journal of Virology · doi:10.1128/jvi.63.8.3220-3226.1989 · Cited by 239 · see citing works
Developmental Switches in Chemokine Response Profiles during B Cell Differentiation and Maturation
Bowman, E. P., Campbell, J. J., Soler, D. F., Dong, Z., Manlongat, N., Picarella, D., Hardy, R. R., & Butcher, E. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1303 · Cited by 212 · see citing works
Andrew, D. P., Ruffing, N., Kim, C. H., Miao, W., Heath, H., Li, Y., Murphy, K. E., Campbell, J. J., Butcher, E. C., & Wu, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.103 · Cited by 198 · see citing works
Yamamoto, J., Adachi, Y., Onoue, Y., Adachi, Y. S., Okabe, Y., Itazawa, T., Toyoda, M., Seki, T., Morohashi, M., Matsushima, K., et al. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.4.568 · Cited by 195 · see citing works
Self-citationJones, D., Benjamin, R. J., Shahsafaei, A., & Dorfman, D. M. (2000) · Blood · doi:10.1182/blood.v95.2.627 · Cited by 188 · see citing works
Jones, D., O’Hara, C., Kraus, M. D., Pérez‐Atayde, A. R., Shahsafaei, A., Wu, L., & Dorfman, D. M. (2000) · Blood · doi:10.1182/blood.v96.2.685 · Cited by 151 · see citing works
The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis
Trentin, L., Agostini, C., Facco, M., Piazza, F., Perin, A., Siviero, M., Gurrieri, C., Galvan, S., Adami, F., Zambello, R., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7335 · Cited by 141 · see citing works
Miura, S., Ohtani, K., Numata, N., Niki, M., Ohbo, K., Ina, Y., Gojobori, T., Tanaka, Y., Tozawa, H., & Nakamura, M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1313 · Cited by 138 · see citing works
Storek, J., Joseph, A., Espino, G., Dawson, M. A., Douek, D. C., Sullivan, K. M., Flowers, M. E. D., Martin, P. J., Mathioudakis, G., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v98.13.3505 · Cited by 134 · see citing works
Cesarman, E., Chadburn, A., Inghirami, G., Gaïdano, G., & Knowles, D. (1992) · Blood · doi:10.1182/blood.v80.12.3205.3205 · Cited by 131 · see citing works
Hasegawa, H., Nomura, T., Kohno, M., Tateishi, N., Suzuki, Y., Maeda, N., Fujisawa, R., Yoshie, O., & Fujita, S. (2000) · Blood · doi:10.1182/blood.v95.1.30 · Cited by 126 · see citing works
Self-citationSpeiser, D. E., Valmori, D., Rimoldi, D., Pittet, M. J., Líénard, D., Cerundolo, V., MacDonald, H. R., Cerottini, J., & Romero, P. J. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199906)29:06 · Cited by 119 · see citing works
Suppression of tuberculin skin reaction in healthy HTLV‐I carriers from Japan
TACHIBANA, N., Okayama, A., Ishizaki, J., Yokota, T., SHISHIME, E., Murai, K., Shioiri, S., Tsuda, K., Essex, M., & Mueller, N. E. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420605 · Cited by 113 · see citing works
Katou, F., Ohtani, H., Nakayama, T., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64077-1 · Cited by 104 · see citing works
Self-citationFeatures of the Cytokines Secreted by Adult T Cell Leukemia (ATL) Cells
Yamada, Y., Ohmoto, Y., Hata, T., Yamamura, M., Murata, K., Tsukasaki, K., Kohno, T., Chen, Y., Kamihira, S., & Tomonaga, M. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609093442 · Cited by 90 · see citing works
Self-citationImura, A., Hori, T., Imada, K., Kawamata, S., Tanaka, Y., Imamura, S., & Uchiyama, T. (1997) · Blood · doi:10.1182/blood.v89.8.2951 · Cited by 86 · see citing works
HEALD, P. W., Yan, S.-L., Edelson, R. L., et al. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12364814 · Cited by 85 · see citing works
Fukudome, K., Furuse, M., Fukuhara, N., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520316 · Cited by 79 · see citing works
Elo, J. P., Akinola, L. A., POUTANEN, M. H., Vihko, P., Kyllönen, A. P., Lukkarinen, O. A., & Vihko, R. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960328)66:1 · Cited by 69 · see citing works
Decreased reactivity to PPD among htlv‐i carriers in relation to virus and hematologic status
Welles, S. L., TACHIBANA, N., Okayama, A., Shioiri, S., Ishihara, S., Murai, K., & Mueller, N. E. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560307 · Cited by 66 · see citing works
Takagi, S., Fujikawa, K., Imai, T., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610519 · Cited by 65 · see citing works
Tanaka, Y., Kimata, K., Wake, A., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.5.1987 · Cited by 60 · see citing works
Ishikawa, T., Imura, A., Tanaka, K., et al. (1993) · Blood · doi:10.1182/blood.v82.5.1590.1590 · Cited by 59 · see citing works
Tanaka, Y., Hayashi, M., Takagi, S., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8508-8517.1996 · Cited by 58 · see citing works
Viral Aetiology of Adult T-Cell Leukaemia
Yamamoto, N., & Hinuma, Y. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-8-1641 · Cited by 57 · see citing works
Valentin, H., Lemasson, I., Hamaia, S. W., Casse, H., König, S., Devaux, C. A., & Gazzolo, L. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8522-8530.1997 · Cited by 46 · see citing works
Katsuki, T., Katsuki, K., Imai, J., & Hinuma, Y. (1987) · PubMed · Cited by 46 · see citing works
Setoyama, M., Kerdel, F. A., Elgart, G. W., Kanzaki, T., & BYRNES, J. J. (1998) · Europe PMC (PubMed Central) · Cited by 39 · see citing works
Imai, T., Tanaka, Y., Fukudome, K., et al. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550520 · Cited by 23 · see citing works
Sagawa, K., Mochizuki, M., Katagiri, K., et al. (1996) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1996.tb01082.x · Cited by 16 · see citing works
Histopathological definition of the adult and calf types of bovine leukosis.
Yamamoto, H., Yoshino, T., Matsuda, I., et al. (1982) · PubMed · Cited by 8 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- [28]28. Loetscher M, Gerber B, Loetscher P, et al. Che- mokine receptor specific for IP10 and mig: struc- ture, function, and expression in activated T-lym- phocytes. J Exp Med. 1996;184:963-969.
- [39]39. Baba M, Imai T, Yoshida T, Yoshie O. Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type 1: role of the viral transactivator Tax. Int J Cancer. 1996;66:124-129.
- [47]47. Kanazawa N, Nakamura T, Tashiro K, et al. Frac- talkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur J Immunol. 1999;29: 1925-1932.
Cited by
Sorted by citations
Ishida, T., Joh, T., Uike, N., Yamamoto, K., Utsunomiya, A., Yoshida, S., Saburi, Y., Miyamoto, T., Takemoto, S., Suzushima, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.3472 · Cited by 657 · see citing works
Yamano, Y., Araya, N., Sato, T., Utsunomiya, A., Azakami, K., Hasegawa, D., Izumi, T., Fujita, H., Aratani, S., Yagishita, N., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006517 · Cited by 140 · see citing works
Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy
Sato, T., Coler-Reilly, A. L. G., Yagishita, N., Araya, N., Inoue, E., Furuta, R., Watanabe, T., Uchimaru, K., Matsuoka, M., Matsumoto, N., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1704827 · Cited by 113 · see citing works
Phillips, A. A., Fields, P. A., Hermine, O., Ramos, J. C., Beltran, B. E., Pereira, J., Wandroo, F., Feldman, T., Taylor, G. P., Sawas, A., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.205096 · Cited by 70 · see citing works
Current State of Therapeutics for HTLV-1
Wang, T. T., Hirons, A., Doerflinger, M., Morris, K. V., Ledger, S., Purcell, D. F. J., Kelleher, A. D., & Ahlenstiel, C. L. (2024) · Viruses · doi:10.3390/v16101616 · Cited by 22 · see citing works
“Treatments for HTLV-1-associated diseases and infection.”
- Authors
- Yoshie, O., Fujisawa, R., Nakayama, T., Harasawa, H., Tago, H., Izawa, D., Hieshima, K., Tatsumi, Y., Matsushima, K., Hasegawa, H., Kanamaru, A., Kamihira, S., & Yamada, Y.
- Affiliations
- Tohoku University (JP)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-03-01
- Volume
- 99
- Issue
- 5
- Pages
- 1505-1511
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2110220145
- Cited by
- 326
- References
- 49
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 11 · 2023: 15 · 2022: 11 · 2021: 22 · 2020: 15 · 2019: 19 · 2018: 17 · 2017: 18 · 2016: 13 · 2015: 16 · 2014: 23 · 2013: 14 · 2012: 9
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- CCR4, adult T-cell leukemia/lymphoma, HTLV-1, chemokine receptors, TARC/CCL17, MDC/CCL22, chemotaxis, CD4+ T cells, Th2 polarization, skin lesions, lymph node invasion, T-cell immortalization
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cell Line, Transformed, Chemotaxis, Leukocyte, Female, Humans, Male, Middle Aged, RNA, Messenger, Skin, T-Lymphocytes, Human T-lymphotropic virus 1, Leukemia-Lymphoma, Adult T-Cell, Gene Products, tax, Jurkat Cells, Receptors, Chemokine, Chemokines, CC, Receptors, CCR4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review